Anzemet and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Anzemet (dolasetron mesylate) and Revlimid (lenalidomide). Common drug interactions include ingrowing nail among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Anzemet and Revlimid. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

On Jul, 13, 2026

31 people who take Anzemet and Revlimid together, and have interactions are studied.

What are the common drug interactions of Anzemet and Revlimid, by gender? *:

female:

Ingrowing nail
Intervertebral disc protrusion (spinal disc protrusion)
Malaise (a feeling of general discomfort or uneasiness)
Nephrolithiasis (calculi in the kidneys)
Nocturia (the need to get up in the night to urinate)
Onychomycosis (fungal infection of the nail)
Palpitations (feelings or sensations that your heart is pounding or racing)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Poor quality sleep
Pulmonary hypertension (increase in blood pressure in the lung artery)

male:

Anaemia (lack of blood)
Back pain
Confusional state
Deafness
Death
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dehydration (dryness resulting from the removal of water)
Dental caries
Dental plaque (film of mucus and bacteria deposited on the teeth that encourages the development of dental caries)
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)

What are the common drug interactions of Anzemet and Revlimid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Renal failure acute (rapid kidney dysfunction)
Abdominal pain
Myocarditis (inflammation of heart muscle myocardium)
Abscess jaw (tooth abscess or root abscess)
Actinic keratosis (skin disease due to sun exposure)
Aggression
Alopecia (absence of hair from areas of the body)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Anxiety

50-59:

Anaemia (lack of blood)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Thrombocytopenia (decrease of platelets in blood)
Activated partial thromboplastin time prolonged
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Arthralgia (joint pain)
Back pain
Bone disorder
Bone erosion

60+:

Fatigue (feeling of tiredness)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Back pain
Bladder cancer recurrent
Blood pressure increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Cardiomegaly (increased size of heart than normal)
Carotid artery stenosis (narrowing of carotid artery)
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)

What are the existing conditions these people have? *

Pain: 2 people, 6.45%
Nausea (feeling of having an urge to vomit): 2 people, 6.45%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 6.45%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Anzemet and Revlimid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously